← Leaderboards
Dirk Gillespie
Rush University Medical Center
$1,333,628
Attributed
$2,667,255
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $677.5K · FY2021–24$1M$750K$500K$250K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,667,255 · 1
By mechanism
R01$2,667,255 · 1
Top collaborators
- Michael Fill4 shared
Most similar at Rush University Medical Center
Same institution · by research overlap
- Eduardo Rios$10,281,644
- Lynda H Powell$29,229,513
- Thomas R Shannon$2,953,522
- Sheila Riazi$887,233
- Elizabeth B Lynch$15,922,721
Others in their field
Other Emerging Leaders on “Analog”
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$15,023,002
- Jeffrey Reich · Sparian Biosciences, Inc.$14,845,721
- Thomas Dick · Rbhs-New Jersey Medical School$14,469,725
- Terry Roemer · Prokaryotics, Inc.$14,198,753
Research focus
AnalogBehaviorArrhythmiaCalciumCalsequestrinCarvedilolCatalogsCatecholaminergic Polymorphic Ventricular TachycardiaCellsClinically RelevantComplexDiastoleDrug TargetingEventFailureFallsFeedbackFoundationsGeometryHeartHousingHybridsInnovationInsight
Grant awards (4)
Collective Ryanodine Receptor Operation at Release Sites$654,349
R01 · FY2024 · HL
Collective Ryanodine Receptor Operation at Release Sites$667,702
R01 · FY2023 · HL
Collective Ryanodine Receptor Operation at Release Sites$667,702
R01 · FY2022 · HL
Collective Ryanodine Receptor Operation at Release Sites$677,502
R01 · FY2021 · HL